Menarini has signed the acquisition of the Lodichem’s pharmaceutical active ingredients manufacturing facility from Euticals. An investment of 10 million euro is planned for the development and re-launch of the facility, that will complement the Menarini plants of Pisa and Lomagna. Lodichem will produce high-quality active ingredients for strategic products. The project involves the construction of a new building for offices and quality-control laboratories, as well the refurbishing of numerous systems. The acquisition comes two months after the creation of VaxYnethic, a joint venture in the field of biopharmaceutical production signed between Menarini and BiosYnth.